IVOR ROYSTON
CIK 1026765 · CEO & President · last filed 2024-11-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$11.42M
Companies
4
Total Filings
51
Lifetime Open-Market Net
$1.76M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Viracta Therapeutics, Inc. (VIRX) Delisted | Director | 858,340 | $0.01 | $8.4K | -$208.4K | 19 | 2024-11-27 |
| BIOCEPT INC (BIOC) Delisted | Director | 34,152 | $0.43 | $14.9K | $64.6K | 14 | 2022-09-08 |
| SNDX | Director | 625,545 | $18.25 | $11.42M | $1.80M | 3 | 2017-03-22 |
| MMRGlobal, Inc. (FVRL) Delisted | Director | 123,155 | — | — | $105.2K | 3 | 2007-11-06 |
Recent Filings · Page 6 of 6
51 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-01-03 | MMRGlobal, Inc. (FVRL) Delisted | Buy (P) | +40,000 | $105.2K | EDGAR |
Showing 51–51 of 51
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.